TC Biopharm (Holdings) Plc (TCBP )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol TCBP
- Company TC Biopharm (Holdings) Plc
- Price $2.27
- Changes Percentage -55.14
- Change -2.79
- Day Low $1.89
- Day High $5.04
- Year High $1140
- Year Low $1.89
- Market Cap $725,295
- Price Avg 50 EMA (D) $5.42
- Price Avg 200 EMA (D) $10.85
- Exchange NASDAQ
- Volume 2,656,563
- Average Volume 246,606
- Open $4.97
- Previous Close $5.06
- EPS -197.43
- PE -0.01
- Earnings Announcement 2024-11-27 12:00:00
- Shares Outstanding $319,513
Company brief: TC BIOPHARM (HOLDINGS) PLC (TCBP )
- Healthcare
- Biotechnology
- Mr. Bryan L. Kobel
- https://www.tcbiopharm.com
- GB
- N/A
- 02-11-2022
- US87807D4007
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.